Vitamin D as a possible biomarker of mild cognitive impairment in parkinsonians.

Gabriella SantangeloSimona RaimoRoberto ErroMarina PicilloMarianna AmboniMaria Teresa PellecchiaClaudia PivonelloPaolo BaroneCarmine Vitale

Published in: Aging & mental health (2020)

Our results demonstrated that a lower level of 25(OH)D is conceivable as a biomarker of development of PD-MCI throughout the disease. Early diagnosis of Vitamin D insufficiency and its management might be useful to prevent cognitive decline in PD patients.

Keyphrases

mild cognitive impairment
cognitive decline
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors